Company / Gross Profit
ATOSSA THERAPEUTICS, INC. Gross Profit History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
-$130.7K
FY2016
5-year range
-$130.7K / $416.2K
FY2012-FY2016
Trend
-425.5%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit changed -426% YoY in FY2016, a notable deviation from the 4-year average annual change of -7%.
Based on SEC 10-K filings.
-$130,653 in FY2016.
Declined from $137,093 to -$130,653 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ATOSSA THERAPEUTICS, INC.'s gross profit has declined for 3 consecutive years.
- In FY2016, gross profit decreased 425.5% year-over-year.
- Peak gross profit was recorded in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | -$130.7K | -425.5% |
| FY2015 | $40.1K | -70.7% |
| FY2014 | $137.1K | -67.1% |
| FY2013 | $416.2K | +535.0% |
| FY2012 | -$95.7K | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026